메뉴 건너뛰기




Volumn 32, Issue 8, 2014, Pages 938-943

Efficient lysis of epithelial ovarian cancer cells by MAGE-A3-induced cytotoxic T lymphocytes using rAAV-6 capsid mutant vector

Author keywords

Adeno associated Virus 6; Capsid tyrosine mutant; Cytotoxic T lymphocytes; Dendritic cells; Epithelial ovarian cancer; MAGE A3

Indexed keywords

GAMMA INTERFERON; MELANOMA ANTIGEN 3; VIRUS VECTOR;

EID: 84892969947     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2013.12.049     Document Type: Article
Times cited : (19)

References (41)
  • 2
    • 84863250697 scopus 로고    scopus 로고
    • Survival rates for International Federation of Gynecology and Obstetrics stage III ovarian carcinoma by cell type: a study of 262 unselected patients with uniform pathologic review
    • Seidman J.D., Yemelyanova A., Cosin J.A., Smith A., Kurman R.J. Survival rates for International Federation of Gynecology and Obstetrics stage III ovarian carcinoma by cell type: a study of 262 unselected patients with uniform pathologic review. Int J Gynecol Cancer 2012, 22:367-371.
    • (2012) Int J Gynecol Cancer , vol.22 , pp. 367-371
    • Seidman, J.D.1    Yemelyanova, A.2    Cosin, J.A.3    Smith, A.4    Kurman, R.J.5
  • 3
    • 84857793524 scopus 로고    scopus 로고
    • Decisions about dendritic cells: past, present, and future
    • Steinman R.M. Decisions about dendritic cells: past, present, and future. Annu Rev Immunol 2012, 30:1-22.
    • (2012) Annu Rev Immunol , vol.30 , pp. 1-22
    • Steinman, R.M.1
  • 4
    • 79955630348 scopus 로고    scopus 로고
    • Engineering dendritic cells to enhance cancer immunotherapy
    • Boudreau J.E., Bonehill A., Thielemans K., Wan Y. Engineering dendritic cells to enhance cancer immunotherapy. Mol Ther 2011, 19:841-853.
    • (2011) Mol Ther , vol.19 , pp. 841-853
    • Boudreau, J.E.1    Bonehill, A.2    Thielemans, K.3    Wan, Y.4
  • 5
    • 2942559009 scopus 로고    scopus 로고
    • Cancer immunotherapy with mRNA-transfected dendritic cells
    • Gilboa E., Vieweg J. Cancer immunotherapy with mRNA-transfected dendritic cells. Immunol Rev 2004, 199:251-263.
    • (2004) Immunol Rev , vol.199 , pp. 251-263
    • Gilboa, E.1    Vieweg, J.2
  • 6
    • 84892996730 scopus 로고    scopus 로고
    • Design of an optimized Wilms' tumor 1 (WT1) mRNA construct for enhanced WT1 expression and improved immunogenicity in vitro and in vivo
    • Benteyn D., Anguille S., Van Lint S., Heirman C., Van Nuffel A.M., Corthals J., et al. Design of an optimized Wilms' tumor 1 (WT1) mRNA construct for enhanced WT1 expression and improved immunogenicity in vitro and in vivo. Mol Ther Nucleic Acids 2013, 2:e134.
    • (2013) Mol Ther Nucleic Acids , vol.2
    • Benteyn, D.1    Anguille, S.2    Van Lint, S.3    Heirman, C.4    Van Nuffel, A.M.5    Corthals, J.6
  • 8
    • 84869175164 scopus 로고    scopus 로고
    • Dendritic cell-based tumor vaccinations in epithelial ovarian cancer: a systematic review
    • Tanyi J.L., Chu C.S. Dendritic cell-based tumor vaccinations in epithelial ovarian cancer: a systematic review. Immunotherapy 2012, 4:995-1009.
    • (2012) Immunotherapy , vol.4 , pp. 995-1009
    • Tanyi, J.L.1    Chu, C.S.2
  • 9
    • 54249126862 scopus 로고    scopus 로고
    • Gene therapy using adeno-associated virus vectors
    • Daya S., Berns K.I. Gene therapy using adeno-associated virus vectors. Clin Microbiol Rev 2008, 21:583-593.
    • (2008) Clin Microbiol Rev , vol.21 , pp. 583-593
    • Daya, S.1    Berns, K.I.2
  • 10
    • 0036147989 scopus 로고    scopus 로고
    • Efficient generation of cytotoxic T lymphocytes against cervical cancer cells by adeno-associated virus/human papillomavirus type 16 E7 antigen gene transduction into dendritic cells
    • Chiriva-Internati M., Liu Y., Salati E., Zhou W., Wang Z., Grizzi F., et al. Efficient generation of cytotoxic T lymphocytes against cervical cancer cells by adeno-associated virus/human papillomavirus type 16 E7 antigen gene transduction into dendritic cells. Eur J Immunol 2002, 32:30-38.
    • (2002) Eur J Immunol , vol.32 , pp. 30-38
    • Chiriva-Internati, M.1    Liu, Y.2    Salati, E.3    Zhou, W.4    Wang, Z.5    Grizzi, F.6
  • 11
    • 0034856182 scopus 로고    scopus 로고
    • Adeno-associated virus type 2-mediated transduction of human monocyte-derived dendritic cells: implications for ex vivo immunotherapy
    • Ponnazhagan S., Mahendra G., Curiel D.T., Shaw D.R. Adeno-associated virus type 2-mediated transduction of human monocyte-derived dendritic cells: implications for ex vivo immunotherapy. J Virol 2001, 75:9493-9501.
    • (2001) J Virol , vol.75 , pp. 9493-9501
    • Ponnazhagan, S.1    Mahendra, G.2    Curiel, D.T.3    Shaw, D.R.4
  • 12
    • 34248395538 scopus 로고    scopus 로고
    • Major subsets of human dendritic cells are efficiently transduced by self-complementary adeno-associated virus vectors 1 and 2
    • Veron P., Allo V., Riviere C., Bernard J., Douar A-M., Masurier C. Major subsets of human dendritic cells are efficiently transduced by self-complementary adeno-associated virus vectors 1 and 2. J Virol 2007, 81:5385-5394.
    • (2007) J Virol , vol.81 , pp. 5385-5394
    • Veron, P.1    Allo, V.2    Riviere, C.3    Bernard, J.4    Douar, A.-M.5    Masurier, C.6
  • 13
    • 29244438789 scopus 로고    scopus 로고
    • Enhanced transduction of mouse bone marrow-derived dendritic cells by repetitive infection with self-complementary adeno-associated virus 6 combined with immunostimulatory ligands
    • Aldrich W., Ren C., White A., Zhou S., Kumar S., Jenkins C., et al. Enhanced transduction of mouse bone marrow-derived dendritic cells by repetitive infection with self-complementary adeno-associated virus 6 combined with immunostimulatory ligands. Gene Ther 2005, 13:29-39.
    • (2005) Gene Ther , vol.13 , pp. 29-39
    • Aldrich, W.1    Ren, C.2    White, A.3    Zhou, S.4    Kumar, S.5    Jenkins, C.6
  • 14
    • 78650082356 scopus 로고    scopus 로고
    • Optimized transduction of human monocyte-derived dendritic cells by recombinant adeno-associated virus serotype 6
    • Ussher J.E., Taylor J.A. Optimized transduction of human monocyte-derived dendritic cells by recombinant adeno-associated virus serotype 6. Hum Gene Ther 2010, 21:1675-1686.
    • (2010) Hum Gene Ther , vol.21 , pp. 1675-1686
    • Ussher, J.E.1    Taylor, J.A.2
  • 15
    • 84893872048 scopus 로고    scopus 로고
    • Rationally designed capsid and transgene cassette of AAV6 vectors for dendritic cell-based cancer immunotherapy
    • Pandya J., Ortiz L., Ling C., Rivers A.E., Aslanidi G. Rationally designed capsid and transgene cassette of AAV6 vectors for dendritic cell-based cancer immunotherapy. Immunol Cell Biol 2013.
    • (2013) Immunol Cell Biol
    • Pandya, J.1    Ortiz, L.2    Ling, C.3    Rivers, A.E.4    Aslanidi, G.5
  • 16
    • 84864380076 scopus 로고    scopus 로고
    • MAGE-A antigens as targets in tumour therapy
    • Meek D.W., Marcar L. MAGE-A antigens as targets in tumour therapy. Cancer Lett 2012, 324:126-132.
    • (2012) Cancer Lett , vol.324 , pp. 126-132
    • Meek, D.W.1    Marcar, L.2
  • 17
    • 35748979692 scopus 로고    scopus 로고
    • Immunological profiling of a panel of human ovarian cancer cell lines
    • Carr T.M., Adair S.J., Fink M.J., Hogan K.T. Immunological profiling of a panel of human ovarian cancer cell lines. Cancer Immunol Immunother 2008, 57:31-42.
    • (2008) Cancer Immunol Immunother , vol.57 , pp. 31-42
    • Carr, T.M.1    Adair, S.J.2    Fink, M.J.3    Hogan, K.T.4
  • 18
    • 77951222450 scopus 로고    scopus 로고
    • Expression of tumor-specific antigen MAGE, GAGE and BAGE in ovarian cancer tissues and cell lines
    • Zhang S., Zhou X., Yu H., Yu Y. Expression of tumor-specific antigen MAGE, GAGE and BAGE in ovarian cancer tissues and cell lines. BMC Cancer 2010, 10:163.
    • (2010) BMC Cancer , vol.10 , pp. 163
    • Zhang, S.1    Zhou, X.2    Yu, H.3    Yu, Y.4
  • 19
    • 22144476522 scopus 로고    scopus 로고
    • Hematopoietic stem cell transduction by recombinant adeno-associated virus vectors: problems and solutions
    • Srivastava A. Hematopoietic stem cell transduction by recombinant adeno-associated virus vectors: problems and solutions. Hum Gene Ther 2005, 16:792-798.
    • (2005) Hum Gene Ther , vol.16 , pp. 792-798
    • Srivastava, A.1
  • 21
    • 0034663292 scopus 로고    scopus 로고
    • High incidence of chromosome 13 deletion in multiple myeloma detected by multiprobe interphase FISH
    • Shaughnessy J., Tian E., Sawyer J., Bumm K., Landes R., Badros A., et al. High incidence of chromosome 13 deletion in multiple myeloma detected by multiprobe interphase FISH. Blood 2000, 96:1505-1511.
    • (2000) Blood , vol.96 , pp. 1505-1511
    • Shaughnessy, J.1    Tian, E.2    Sawyer, J.3    Bumm, K.4    Landes, R.5    Badros, A.6
  • 22
    • 84892998510 scopus 로고    scopus 로고
    • Intra-and intertumoral variation in the expression of cancer testis antigens, MAGE-3 and NY-ESO-1 in multiple myeloma
    • Gupta S., Pei L., Droojenbroeck J., Szmania S., Yacobby S., Batchu R., et al. Intra-and intertumoral variation in the expression of cancer testis antigens, MAGE-3 and NY-ESO-1 in multiple myeloma. Blood 2002, 2002.
    • (2002) Blood , pp. 2002
    • Gupta, S.1    Pei, L.2    Droojenbroeck, J.3    Szmania, S.4    Yacobby, S.5    Batchu, R.6
  • 23
    • 20844432364 scopus 로고    scopus 로고
    • NY-ESO-1 is highly expressed in poor-prognosis multiple myeloma and induces spontaneous humoral and cellular immune responses
    • Van Rhee F., Szmania S.M., Zhan F., Gupta S.K., Pomtree M., Lin P., et al. NY-ESO-1 is highly expressed in poor-prognosis multiple myeloma and induces spontaneous humoral and cellular immune responses. Blood 2005, 105:3939-3944.
    • (2005) Blood , vol.105 , pp. 3939-3944
    • Van Rhee, F.1    Szmania, S.M.2    Zhan, F.3    Gupta, S.K.4    Pomtree, M.5    Lin, P.6
  • 24
    • 10744225491 scopus 로고    scopus 로고
    • High-level expression of cancer/testis antigen NY-ESO-1 and human granulocyte-macrophage colony-stimulating factor in dendritic cells with a bicistronic retroviral vector
    • Batchu R., Moreno A., Szmania S., Gupta S., Zhan F., Rosen N., et al. High-level expression of cancer/testis antigen NY-ESO-1 and human granulocyte-macrophage colony-stimulating factor in dendritic cells with a bicistronic retroviral vector. Hum Gene Ther 2003, 14:1333-1345.
    • (2003) Hum Gene Ther , vol.14 , pp. 1333-1345
    • Batchu, R.1    Moreno, A.2    Szmania, S.3    Gupta, S.4    Zhan, F.5    Rosen, N.6
  • 25
    • 77958102381 scopus 로고    scopus 로고
    • Adeno-associated virus serotype 6 capsid tyrosine-to-phenylalanine mutations improve gene transfer to skeletal muscle
    • Qiao C., Zhang W., Yuan Z., Shin J-H., Li J., Jayandharan G.R., et al. Adeno-associated virus serotype 6 capsid tyrosine-to-phenylalanine mutations improve gene transfer to skeletal muscle. Hum Gene Ther 2010, 21:1343-1348.
    • (2010) Hum Gene Ther , vol.21 , pp. 1343-1348
    • Qiao, C.1    Zhang, W.2    Yuan, Z.3    Shin, J.-H.4    Li, J.5    Jayandharan, G.R.6
  • 26
    • 29444442811 scopus 로고    scopus 로고
    • Intraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8+/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer
    • Sato E., Olson S.H., Ahn J., Bundy B., Nishikawa H., Qian F., et al. Intraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8+/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer. PNAS 2005, 102:18538-18543.
    • (2005) PNAS , vol.102 , pp. 18538-18543
    • Sato, E.1    Olson, S.H.2    Ahn, J.3    Bundy, B.4    Nishikawa, H.5    Qian, F.6
  • 28
    • 82455175361 scopus 로고    scopus 로고
    • MAGE-A family: attractive targets for cancer immunotherapy
    • Sang M., Lian Y., Zhou X., Shan B. MAGE-A family: attractive targets for cancer immunotherapy. Vaccine 2011, 29:8496-8500.
    • (2011) Vaccine , vol.29 , pp. 8496-8500
    • Sang, M.1    Lian, Y.2    Zhou, X.3    Shan, B.4
  • 29
    • 84880730418 scopus 로고    scopus 로고
    • Selection of immunostimulant AS15 for active immunization with MAGE-A3 protein: results of a randomized phase II study of the European Organisation for Research and Treatment of Cancer Melanoma Group in Metastatic Melanoma
    • Kruit W.H., Suciu S., Dreno B., Mortier L., Robert C., Chiarion-Sileni V., et al. Selection of immunostimulant AS15 for active immunization with MAGE-A3 protein: results of a randomized phase II study of the European Organisation for Research and Treatment of Cancer Melanoma Group in Metastatic Melanoma. J Clin Oncol 2013, 31:2413-2420.
    • (2013) J Clin Oncol , vol.31 , pp. 2413-2420
    • Kruit, W.H.1    Suciu, S.2    Dreno, B.3    Mortier, L.4    Robert, C.5    Chiarion-Sileni, V.6
  • 30
    • 42549106307 scopus 로고    scopus 로고
    • Final results of a multi-center, double-blind, randomized, placebo-controlled phase II study to assess the efficacy of MAGE-A3 immunotherapeutic as adjuvant therapy in stage IB/II non-small cell lung cancer (NSCLC)
    • Vansteenkiste J., Zielinski M., Linder A., Dahabre J., Esteban E., Malinowski W., et al. Final results of a multi-center, double-blind, randomized, placebo-controlled phase II study to assess the efficacy of MAGE-A3 immunotherapeutic as adjuvant therapy in stage IB/II non-small cell lung cancer (NSCLC). J Clin Oncol 2007, 25:7554.
    • (2007) J Clin Oncol , vol.25 , pp. 7554
    • Vansteenkiste, J.1    Zielinski, M.2    Linder, A.3    Dahabre, J.4    Esteban, E.5    Malinowski, W.6
  • 31
    • 33746707463 scopus 로고    scopus 로고
    • Methylation and expression analysis of 15 genes and three normally-methylated genes in 13 ovarian cancer cell lines
    • Imura M., Yamashita S., Cai L.Y., Furuta J., Wakabayashi M., Yasugi T., et al. Methylation and expression analysis of 15 genes and three normally-methylated genes in 13 ovarian cancer cell lines. Cancer Lett 2006, 241:213-220.
    • (2006) Cancer Lett , vol.241 , pp. 213-220
    • Imura, M.1    Yamashita, S.2    Cai, L.Y.3    Furuta, J.4    Wakabayashi, M.5    Yasugi, T.6
  • 32
    • 79954455826 scopus 로고    scopus 로고
    • Epigenetic modulation of MAGE-A3 antigen expression in multiple myeloma following treatment with the demethylation agent 5-azacitidine and the histone deacetlyase inhibitor MGCD0103
    • Moreno-Bost A., Szmania S., Stone K., Garg T., Hoerring A., Szymonifka J., et al. Epigenetic modulation of MAGE-A3 antigen expression in multiple myeloma following treatment with the demethylation agent 5-azacitidine and the histone deacetlyase inhibitor MGCD0103. Cytotherapy 2011, 13:618-628.
    • (2011) Cytotherapy , vol.13 , pp. 618-628
    • Moreno-Bost, A.1    Szmania, S.2    Stone, K.3    Garg, T.4    Hoerring, A.5    Szymonifka, J.6
  • 33
    • 59449088943 scopus 로고    scopus 로고
    • Treatment of ovarian cancer cell lines with 5-aza-2'-deoxycytidine upregulates the expression of cancer-testis antigens and class I major histocompatibility complex-encoded molecules
    • Adair S.J., Hogan K.T. Treatment of ovarian cancer cell lines with 5-aza-2'-deoxycytidine upregulates the expression of cancer-testis antigens and class I major histocompatibility complex-encoded molecules. Cancer Immunol Immunother 2009, 58:589-601.
    • (2009) Cancer Immunol Immunother , vol.58 , pp. 589-601
    • Adair, S.J.1    Hogan, K.T.2
  • 34
    • 84856520424 scopus 로고    scopus 로고
    • Immunity and AAV-mediated gene therapy for muscular dystrophies in large animal models and human trials
    • Wang Z., Tapscott S.J., Chamberlain J.S., Storb R. Immunity and AAV-mediated gene therapy for muscular dystrophies in large animal models and human trials. Front Microbiol 2011, 2:201.
    • (2011) Front Microbiol , vol.2 , pp. 201
    • Wang, Z.1    Tapscott, S.J.2    Chamberlain, J.S.3    Storb, R.4
  • 35
    • 78650239955 scopus 로고    scopus 로고
    • Regulation of the activity of an adeno-associated virus vector cancer vaccine administered with synthetic toll-like receptor agonists
    • Triozzi P.L., Aldrich W., Ponnazhagan S. Regulation of the activity of an adeno-associated virus vector cancer vaccine administered with synthetic toll-like receptor agonists. Vaccine 2010, 28:7837-7843.
    • (2010) Vaccine , vol.28 , pp. 7837-7843
    • Triozzi, P.L.1    Aldrich, W.2    Ponnazhagan, S.3
  • 36
    • 75449109000 scopus 로고    scopus 로고
    • Pseudotyped recombinant adeno-associated viral vectors mediate efficient gene transfer into primary human CD34+ peripheral blood progenitor cells
    • Veldwijk M.R., Sellner L., Stiefelhagen M., Kleinschmidt J.A., Laufs S., Topaly J., et al. Pseudotyped recombinant adeno-associated viral vectors mediate efficient gene transfer into primary human CD34+ peripheral blood progenitor cells. Cytotherapy 2010, 12:107-112.
    • (2010) Cytotherapy , vol.12 , pp. 107-112
    • Veldwijk, M.R.1    Sellner, L.2    Stiefelhagen, M.3    Kleinschmidt, J.A.4    Laufs, S.5    Topaly, J.6
  • 37
    • 84892967754 scopus 로고    scopus 로고
    • Optimizing the transduction efficiency of capsid-modified AAV6 serotype vectors in primary human hematopoietic stem cells in vitro and in a xenograft mouse model in vivo
    • Song L., Kauss M.A., Kopin E., Chandra M., Ul-Hasan T., Miller E., et al. Optimizing the transduction efficiency of capsid-modified AAV6 serotype vectors in primary human hematopoietic stem cells in vitro and in a xenograft mouse model in vivo. Cytotherapy 2013, 15:986-998.
    • (2013) Cytotherapy , vol.15 , pp. 986-998
    • Song, L.1    Kauss, M.A.2    Kopin, E.3    Chandra, M.4    Ul-Hasan, T.5    Miller, E.6
  • 38
    • 16844379997 scopus 로고    scopus 로고
    • Immunosuppressive networks in the tumour environment and their therapeutic relevance
    • Zou W. Immunosuppressive networks in the tumour environment and their therapeutic relevance. Nat Rev Cancer 2005, 5:263-274.
    • (2005) Nat Rev Cancer , vol.5 , pp. 263-274
    • Zou, W.1
  • 39
    • 80655142485 scopus 로고    scopus 로고
    • Continuous CD8+ T-cell priming by dendritic cell cross-presentation of persistent antigen following adeno-associated virus-mediated gene delivery
    • Xu D., Walker C.M. Continuous CD8+ T-cell priming by dendritic cell cross-presentation of persistent antigen following adeno-associated virus-mediated gene delivery. J Virol 2011, 85:12083-12086.
    • (2011) J Virol , vol.85 , pp. 12083-12086
    • Xu, D.1    Walker, C.M.2
  • 40
    • 77954870211 scopus 로고    scopus 로고
    • Differential induction of inflammatory cytokines by dendritic cells treated with novel TLR-agonist and cytokine based cocktails: targeting dendritic cells in autoimmunity
    • Jensen S.S., Gad M. Differential induction of inflammatory cytokines by dendritic cells treated with novel TLR-agonist and cytokine based cocktails: targeting dendritic cells in autoimmunity. J Inflamm (Lond) 2010, 7:37.
    • (2010) J Inflamm (Lond) , vol.7 , pp. 37
    • Jensen, S.S.1    Gad, M.2
  • 41
    • 79151477008 scopus 로고    scopus 로고
    • Development of a successful antitumor therapeutic model combining in vivo dendritic cell vaccination with tumor irradiation and intratumoral GM-CSF delivery
    • Driessens G., Nuttin L., Gras A., Maetens J., Mievis S., Schoore M., et al. Development of a successful antitumor therapeutic model combining in vivo dendritic cell vaccination with tumor irradiation and intratumoral GM-CSF delivery. Cancer Immunol Immunother 2011, 60:273-281.
    • (2011) Cancer Immunol Immunother , vol.60 , pp. 273-281
    • Driessens, G.1    Nuttin, L.2    Gras, A.3    Maetens, J.4    Mievis, S.5    Schoore, M.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.